Marija Punda, M.D., Ph.D.
Dr. Punda graduated at the University of Zagreb School of Medicine in 1997. She completed her residency in Nuclear Medicine at University Hospital Centre “Sestre milosrdnice” in Zagreb in 2009. She attended the Ph.D. program in Biomedicine and Health Sciences, Medical School, University of Zagreb, and defended her Ph.D. thesis “The role of a modified questionnaire as a tool in prediction of low bone mineral density“ in 2014. She attended postgraduate education and courses on several occasions organized by the European Association of Nuclear Medicine (EANM) and the International Atomic Energy Agency (IAEA) in Vienna, Groningen and Brescia. She was involved in numerous Croatian and World congresses and courses in the field of the thyroid, bone densitometry, and osteoporosis.
Dr. Punda works at the Department of Oncology and Nuclear Medicine, University Hospital Centre Sestre Milosrdnice Zagreb from 1999 till now.
She is a member of professional societies including the European Association of Nuclear Medicine (EANM), the Croatian Society of Nuclear Medicine, and the Croatian Thyroid Society. Since 2022 she is a member of the multidisciplinary International Working Group (IWG) on DXA BMD best practices and reporting recommendations.
So far she has published 22 articles, 8 of which were indexed in Current Contents (CC). These publications have been cited 178 times in the Web of Science database (H-index 7). She had at least 20 oral presentations and presented more than 40 abstracts at conferences.
She participates as a teacher in several undergraduate and postgraduate studies in the field of nuclear medicine at the University of Zagreb School of Medicine (since 2011) and as a lecturer at the University of Applied Health Sciences, Zagreb (since 2015).
In 2016 she has been promoted to Research Associate at the University of Zagreb. She was granted the title ‘Primarius’ by the Ministry of Health of the Republic of Croatia in 2021.
The principal interest of dr. Marija Punda is in the field of imaging (nuclear medicine, thyroid ultrasound, bone densitometry) and the treatment of thyroid diseases and osteoporosis.